Press releases

Agreement further diversifies MMV’s partner base, strengthening our antimalarial research and development portfolio

01 April 2015

US$637,000 to support quest to stay ahead of emerging malaria drug resistance 

05 February 2015

Combination could be the long-sought single-dose cure for malaria

20 January 2015

Collaborations set to advance life-saving pre-referral treatment for severe malaria

27 November 2014

An investigational medicine being developed for the treatment and relapse prevention of P. vivax

28 April 2014

A significant milestone reached in partnership with MMV

06 February 2014

US FDA grants expedited approval status for tafenoquine

20 December 2013

Malaria No More and Novartis launch “Power of One”

23 September 2013

New funding for MMV from AusAID

19 August 2013

Historic agreements announced to screen massive drug compound libraries for new treatments

31 May 2013